Proactive - Interviews For Investors podcast

#Trading #Business News #Business #News #Proactive Investors #Gold #Cannabis #Battery Metals #Chief Executive #Biotech #Natural Resources #Bitcoin #Cryptocurrency #Interviews #Investing #Investment Research #Mining #Retail Investment #Technology

30:00

Living together in a group is a strategy many animals use to survive and thrive. And a big part of what makes that living situation successful is listening. In this episode, we explore the collaborative world of the naked mole-rat. Threshold is nonprofit, listener-supported, and independently produced. You can support Threshold by donating today . To stay connected, sign up for our newsletter . Operation frog sound! Send us your frog sounds for an upcoming episode. We want you to go out, listen for frogs and toads, and record them. Just find someone croaking, and hit record on your phone. It doesn’t matter if there’s background noise. It doesn’t even matter if you’re not sure whether or not you’re hearing an amphibian—if you think you are, we would love to get a recording from you. Please also say your name and where you are in the world, and then email the recording to us at outreach@thresholdpodcast.org…

Proactive - Interviews for investors

Series home•Feed

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.

606 episodes

Proactive - Interviews for investors

21 subscribers

updated about an hour ago

Series home•Feed

606 episodes

كل الحلقات

Proactive - Interviews for investors

1
SSV Capital repays £2.5M early, eyes expansion 5:55

1 hour ago5:55

5:55

SSV Capital PLC CEO Ankur Ghosh talked with Proactive about the company’s early loan repayment, expansion in fintech and real estate, and upcoming plans for 2025. SSV Capital has made strides in solidifying its financial position, having repaid a £2.5 million convertible loan note ahead of schedule. Ghosh attributed the decision to strong investor trust and confidence in the company’s banking and fintech operations. “If our balance sheet is strong, why can’t we repay them early?” he stated, highlighting the company's proactive approach even in a challenging financial climate. Ghosh also discussed momentum behind SSV Smart Pay, noting positive reception from both merchants and customers and ambitious targets of scaling to 2 million transactions this year. The initiative incorporates loyalty and cashback schemes and is underpinned by open banking and upcoming embedded finance capabilities. In addition, SSV Capital is progressing in its Proptech development through its SSV Real Estate unit. Ghosh explained that the project has passed alpha and beta testing and is now on track to roll out in the coming months. Looking ahead, the company is focusing on institutional partnerships, establishing a presence as a general partner in Luxembourg, and pursuing FCA licenses as it builds out an equity desk focused on early-stage private equity and venture capital. Visit Proactive's YouTube channel for more insightful interviews and updates. Don't forget to give the video a like, subscribe to the channel, and enable notifications for future content. #SSVCapital #AnkurGhosh #SmartPay #Fintech #OpenBanking #EmbeddedFinance #RealEstateTech #Proptech #PrivateEquity #VentureCapital #FinancialServices #InstitutionalInvestment #InvestorUpdates #FCA #LuxembourgFunds…

Proactive - Interviews for investors

1
Arizona Gold Project yields highest grades for core to Date at Philadelphia Project 3:16

19 hours ago3:16

3:16

Arizona Gold and Silver Vice President of Exploration Greg Hahn spoke with Steve Darling from Proactive to announce a major milestone at the company’s Philadelphia Project in Arizona, reporting the highest gold grades to date from core drilling on the property. The standout result came from drill hole PC25-136, which intersected 4.91 metres grading 9.20 grams per tonne (gpt) gold, highlighting a robust zone of epithermal quartz and calcite-bearing vein breccia within rhyolitic volcanic rocks. Hahn explained that this new high-grade zone, located in the Rising Fawn area, had previously seen limited exploration and lacked the drilling required for a formal resource estimate. The mineralized interval is surrounded by lower-grade stockwork, indicating a broader halo of gold-bearing material. PC25-136 is the first of six drill holes recently completed to test extensions of earlier high-grade intercepts, targeting both down-dip and along-strike mineralization. Hahn noted that the presence of abundant yellow and green quartz in this zone is geologically significant and comparable to mineralization seen in the historic Oatman gold district, suggesting strong potential for further high-grade discoveries. Importantly, this intercept appears to be relatively shallow in the vein system, enhancing the prospectivity as drilling continues to deeper levels. Ongoing drilling at the Philadelphia Project is focused on following up these new results by targeting deeper extensions of the Rising Fawn zone, with the goal of expanding the mineralized envelope and advancing toward a resource definition. #proactiveinvestors #arizonagoldandsilverinc #tsxv #azs #otcqb #azasf #MiningUpdates #GoldExploration #PhiladelphiaProject #MiningDrilling #GoldAndSilver #JuniorMining #ArizonaMining #DrillResults #MiningStocks #PhiladelphiaProject #GregHahn #PreciousMetals #ProactiveInvestors #ResourceExpansion…

Proactive - Interviews for investors

1
Tonix Pharmaceuticals launches :TONIX ONE™ A digital breakthrough in migraine management 4:13

20 hours ago4:13

4:13

Tonix Pharmaceuticals is making waves in the healthcare industry with the launch of TONIX ONE™ a fully integrated digital platform designed to empower migraine patients with better tools for understanding and managing their condition. In an exclusive discussion with Proactive’s Steve Darling, Dr. Seth Lederman, CEO of Tonix Pharmaceuticals, unveiled the platform’s innovative features and strategic partnerships aimed at transforming migraine care. By collaborating with UpScript Telemedicine, ProModRx, Blink Health, and a leading mobile application specializing in disease tracking, symptom reporting, and management, TONIX ONE offers a comprehensive, patient-centric solution. Dr. Lederman highlighted that TONIX ONE™ beyond conventional migraine education by providing critical insights into the limitations of oral medications, which can sometimes result in delayed or ineffective symptom relief. The platform bridges the gap between patients and healthcare providers, offering direct access to migraine specialists via telehealth consultations and seamless e-prescription requests—ensuring a faster, more effective pathway to treatment. With this initiative, Tonix Pharmaceuticals aims to not only educate and empower patients in their treatment journey but also eliminate the barriers to care that many migraine sufferers face. By integrating advanced digital health solutions,TONIX ONE™ stands at the forefront of a new era in migraine management, offering patients greater control over their health and well-being. #proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp #Biotech #MigraineTreatment #TonixOne #DigitalHealth #Telemedicine #ZembraceSymTouch #Tosymra #HealthcareInnovation #PharmaNews #ProactiveInvestors…

Proactive - Interviews for investors

1
Ananda Pharma adds former GW Pharmaceuticals executive as strategic advisor, advances MRX1 4:02

20 hours ago4:02

4:02

Ananda Pharma Plc finance director Jeremy Sturgess-Smith talked with Proactive's Stephen Gunnion about the appointment of Chris Tovey as a strategic advisor. Tovey brings significant experience from his time as chief operating officer at GW Pharmaceuticals and later Jazz Pharmaceuticals. According to Sturgess-Smith: “He’s going to bring all that experience to Ananda,” helping guide the company through its regulatory path and corporate development. Sturgess-Smith also touched on Ananda securing ethics approval to begin its first human trial of MRX1, a key milestone for the company’s therapeutic pipeline. He noted this was the first ethics approval of its kind for any Ananda trial, with recruitment expected to begin shortly in Australia. “It’s very, very exciting to have that ethics approval in the bag,” he said. Looking ahead, the company also expects ethics approvals for studies into chemotherapy-induced peripheral neuropathy and endometriosis in the next six months. For more interviews and updates, visit Proactive's YouTube channel. Don’t forget to like this video, subscribe, and hit the notification bell to stay informed.** #AnandaPharma #MRX1Trial #ClinicalTrials #CannabinoidMedicine #BiotechNews #PharmaceuticalInnovation #EthicsApproval #GWPharma #DrugDevelopment #Epidiolex #HealthInnovation #ProactiveInvestors…

Proactive - Interviews for investors

1
Directa Plus CEO on Q1 revenue jump on new contracts in Romania and textile market recovery 7:01

22 hours ago7:01

7:01

Directa Plus CEO Giulio Cesareo talked with Proactive's Stephen Gunnion about the company’s strong start to 2025 and the strategic impact of its environmental operations. Cesareo shared that the company saw a 40% rise in first-quarter revenue to approximately €2 million, driven by new contracts in Romania and a recovering textile market in Italy. “We have a significant contract with Midia International,” Cesareo explained, adding that work on oil recovery from drilling platforms resumed after a slowdown in 2024 due to the war in the Black Sea. The full acquisition of Setcar, a Romanian environmental service company, plays a central role in the company’s strategy. Cesareo highlighted that Setcar not only holds a full suite of environmental certifications but also occupies a “geopolitical significant position” as a potential gateway to Ukraine’s reconstruction. Environmental applications remain a key focus for Directa Plus, especially the use of its graphene materials to decontaminate water and soil. In collaboration with OMV Petrom, the company successfully decontaminated 44,000 cubic meters of water, recovering 10,000 barrels of crude oil. Research and development are also advancing. Directa Plus is working with Nant G Power on battery materials and refocusing on opportunities in sectors like tyres and PFAS filtration. Cesareo stated, “There are significant opportunities, despite the actual crisis, that can be captured by our innovative material.” With €4 million in cash and a burn rate that extends funding through to August 2026, Cesareo believes the company is well-positioned for the year ahead. For more exclusive interviews and updates, visit Proactive's YouTube channel. Don’t forget to like this video, subscribe, and enable notifications to stay up to date. #DirectaPlus #GrapheneTechnology #EnvironmentalSolutions #Setcar #OilRecovery #PFAS #CleanTech #NantGPower #UkraineReconstruction #TextileInnovation #BatteryMaterials #Q12025 #InvestingInGraphene #ProactiveInvestors…

Proactive - Interviews for investors

1
Pluri CEO Yaky Yanay on pioneering cell-tech solutions for global needs 6:22

22 hours ago6:22

6:22

Pluri Inc. (NASDAQ:PLUR) CEO Yaky Yanay joined Proactive's Stephen Gunnion with more about the company’s progress in developing and commercializing its cell-based technology platform, highlighting recent partnerships, strategic financing, and future milestones. Pluri is a biotechnology company focused on manufacturing products derived from cells—including human, animal, and plant cells—for applications across industries such as healthcare, food, and agriculture. "We are taking this tiny organism, cells... and we create products out of them," Yanay explained. A key highlight was Pluri’s collaboration with Hemafund in Ukraine to enhance the country’s preparedness for radiation emergencies. Yanay detailed the use of PLX-R18, a placenta-based therapeutic developed with US federal agencies, which has shown potential to significantly improve survival rates following radiation exposure. The discussion also covered Pluri’s recent financing activities, including a $10 million raise and the acquisition of cacao company Kokomodo. These moves are part of Pluri’s broader expansion into the food sector, addressing shortages in coffee and cacao through cell cultivation in bioreactors. Looking ahead, Yanay emphasized a strong pipeline of deals for 2025, with a focus on sustainable, cell-based solutions for some of humanity’s biggest needs. For more interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for future content. #PluriInc #BiotechInnovation #CellTherapy #SustainableTech #RadiationPreparedness #CoffeeCrisis #CacaoShortage #HealthcareTech #InvestmentNews #YakyYanay #ProactiveInvestors…

Proactive - Interviews for investors

1
Nostra Terra Oil and Gas CEO on Fouke field growth plans, 5,000 barrels a day target 4:50

22 hours ago4:50

4:50

Nostra Terra Oil and Gas Company PLC CEO Paul Welch talked with Proactive's Stephen Gunnion about the company’s strategy to scale up production and drive growth from its existing base of operations in East Texas and West Texas. Welch explained that Nostra Terra is currently focused on the Pine Mills field, a long-life, shallow onshore field with low operating costs and consistent profitability. “It's been an exciting field for the last 75 years and we expect it to be an exciting field for the program for the next 20 to 30 as well,” he said. Since taking over as CEO around nine months ago, Welch has led the company to profitability by cutting costs and increasing production. He highlighted two successful well workover programs that have effectively doubled production. A key highlight is the Fouke area, where new drilling, including the upcoming Fouke-3 well, could deliver significant volumes. Welch pointed out that these wells can initially produce around 120 barrels per day—compared to the average of 6 to 10 barrels from the Pine Mills wells. If enhanced recovery schemes are implemented, the output could potentially double. Welch reaffirmed the company’s ambitious growth target: “This is a company that's going to be making 5,000 barrels a day in the next 3 to 5 years.” The focus remains on building from a solid, profitable base, with production costs in the Fouke area as low as $3 to $4 per barrel, ensuring resilience across various oil price environments. Watch the full interview to hear more on the outlook for 2025, drilling plans, and the strategic path forward. For more interviews like this, visit Proactive’s YouTube channel. Don’t forget to like the video, subscribe to our channel, and enable notifications to stay updated on the latest content. #NostraTerra #OilAndGas #PaulWelch #TexasOil #PineMillsField #FoukeArea #EnergyStocks #OilProduction #InvestorUpdate #ProactiveInvestors…

Proactive - Interviews for investors

1
North Bay Resources announces first gold concentrate sale from Fran Gold Project 6:34

2 days ago6:34

6:34

North Bay Resources CEO Jared Lazerson joined Steve Darling from Proactive to share news of the company’s first successful gold concentrate sale from a test shipment processed at the Bishop Gold Mill, using ore from the Fran Gold Project. Lazerson confirmed that final acceptance and settlement have been completed, with all refinery requirements met, and assay comparisons for gold, silver, and moisture content agreed upon. The test concentrate represents approximately 10 tons of gross ore, processed through the gravity-only circuit. Lazerson noted this marks an important milestone in the early phase of operations. The flotation circuit, which is expected to significantly enhance recovery rates, is set to come online this month. The company currently has another test shipment in process and has completed a third concentrate shipment, further validating operational momentum. The most recent sale netted approximately $400 per ton, based solely on gravity recovery. However, with further optimization and the integration of the flotation circuit, recoveries are projected to double, potentially reaching over 90% total recovery. This would raise the value per ton to around $800, significantly improving project economics. North Bay Resources currently has 75 tons of ore stockpiled at the Bishop Gold Mill, which will be processed as part of continued optimization and ramp-up. Additionally, there are approximately 5,000 tons of ore stockpiled at the project site, positioning the company for a steady flow of future shipments as operations scale. The CEO also discussed the reinterpretation of 15 years of historical drilling data—104 holes covering 18,000 metres—which has revealed the potential for a bulk tonnage deposit. This reinterpretation aligns with nearby major low-grade, high-volume gold projects like Mount Milligan and Blackwater. #proactiveinvestors #northbayresourcesinc #otc #nbri #PlatinumConcentrate #NorthBayResources #MiningNews #CaliforniaGold #JaredLazerson #GoldRush #ProactiveInvestors #PreciousMetals #MiningUpdates ---#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews…

Proactive - Interviews for investors

1
ATOME signs milestone EPC deal with Casale for Villeta project 3:41

2 days ago3:41

3:41

ATOME PLC (AIM:ATOM) CEO Olivier Mussat talked with Proactive about a landmark milestone for the company’s Villeta green fertiliser project in Paraguay. The company has signed its first definitive engineering, procurement and construction (EPC) agreement with Swiss firm Casale S.A. Mussat explained that this agreement marks the world’s first large-scale green hydrogen fertiliser project to reach the EPC stage, underlining its global relevance. “It’s significant for us as a company because we’ve announced that we had been working on the front-end engineering and design for more than two years now,” Mussat said, noting the long-term collaboration with Casale. He highlighted Casale’s industry-leading expertise, describing the firm as the oldest ammonia licensor globally, with the ability to deliver complex, full-chain fertiliser projects. According to Mussat, the partnership serves as a strategic blueprint for Casale’s future growth. Looking ahead, ATOME aims to reach a final investment decision on the Villeta project by the end of the first half of the year. The company is working to finalise offtake agreements and complete financial documentation for both debt and equity funding. This includes a $115 million equity commitment from Hy24, with further syndication in progress. For more updates on green hydrogen and clean energy developments, visit Proactive’s YouTube channel. Like this video, subscribe, and turn on notifications to stay informed. #ATOMEPLC #GreenHydrogen #EPCContract #FertilizerProject #Casale #SustainableEnergy #CleanTech #HydrogenEconomy #ParaguayProjects #Yara #Hy24…

Proactive - Interviews for investors

1
Kodal Minerals nears completion at Bougouni Lithium project, prepares for exports 3:25

2 days ago3:25

3:25

Kodal Minerals PLC (AIM:KOD) CEO Bernard Aylward takes Proactive's Stephen Gunnion through the company's latest update on its Bougouni lithium project in Mali, where construction is nearly complete and preparations for export are underway. Aylward shared that the optimisation and ramp-up phase of the processing plant has been going well, with over 11,000 tonnes of lithium concentrate already stockpiled and ready for export. "We've been making some adjustments as we go through this process and some improvements to the feed into the crusher... achieving a good product," he said. He noted that the company expects to reach nameplate capacity within the next couple of months, pending a final review and approval by the construction team. Kodal is also progressing steadily on the mining front, with a good run-of-mine (ROM) stockpile in place. The interview highlighted that the mining license transfer process is still ongoing, though Kodal has completed all compliance steps and is now awaiting sign-off from the Committee of Ministers and the President of Mali. Once this is finalised, the company will move forward with export permits and begin shipping product. Visit Proactive’s YouTube channel for more company updates. Don’t forget to like this video, subscribe, and turn on notifications to stay up to date. #KodalMinerals #Lithium #BougouniProject #MiningNews #BatteryMetals #MaliMining #ResourceDevelopment #LithiumProduction #MineralExploration #CriticalMinerals…

Proactive - Interviews for investors

1
Novo Resources targets gold at Tibooburra 5:57

2 days ago5:57

5:57

Novo Resources Corp executive co-chair Mike Spreadborough and exploration manager Kas De Luca talked with Proactive about the company’s current exploration, strategy and key drilling campaigns underway in 2025. Spreadborough detailed the company's focus on standalone projects with the potential to exceed one million ounces, with current efforts centred on drilling programs at the Balla Balla project, Tibooburra Gold Project, and upcoming activity at the John Bull Project. “We’re not chasing brownfields mill feed for an existing processing plant. We’re looking for something new and exciting,” he said. De Luca shared insights into the Clone prospect at Tibooburra, highlighting its strong geological context and mineralisation indicators. “The clone thrust has been really identified and pinpointed now as a foot wall shear zone… that seems to us both in the drilling and in service to carry most of the mineralisation,” she noted. De Luca said results from surface sampling returned grades up to 89 grams per tonne, and the company has only tested a small fraction of a 60km mineralised trend. Novo expects results from three programs between now and July and continues to assess additional farm-in opportunities as part of its strategy. For more videos from Proactive, give this video a like, subscribe to our channel, and turn on notifications so you never miss an update. #GoldExploration #NovoResources #TibooburraGold #GreenfieldsExploration #JuniorMining #RCDrilling #GoldStocks #AustralianMining #MiningUpdates #ProactiveInvestors…

Proactive - Interviews for investors

1
FDA approval sees Orthocell’s Remplir enter multi-billion dollar US nerve market 5:50

2 days ago5:50

5:50

Orthocell Ltd chairman John van der Wielen talked with Proactive about the company receiving FDA clearance for its nerve repair product, Remplir, paving the way for entry into the multi-billion US healthcare market. The approval marks a significant milestone in Orthocell’s international growth strategy and reflects the strength of its regulatory and clinical capabilities. Van der Wielen emphasised the significance of breaking into the US market in a challenging regulatory environment. “Not many people would have thought with the current US turmoil, a company like ours could achieve FDA clearance,” he said. Orthocell has established operations in the US with logistics and distribution already in place. The company is implementing a hybrid sales model using in-house personnel and regional distributors, aiming for rapid initial uptake with an eye on more exclusive arrangements in the future. Remplir’s three-year shelf life and no temperature control requirement make it ideal for streamlined deployment. He also highlighted that Orthocell has already performed over 2,000 procedures in Australia and anticipates the US market to be 20 to 30 times larger, creating a strong revenue opportunity. With $32 million in cash reserves, the company expects to become cash flow positive within two years. 👉 For more interviews and updates, head to Proactive’s YouTube channel. Don’t forget to like the video, subscribe, and turn on notifications. #Orthocell #FDAApproval #Remplir #NerveRepair #MedicalDevices #BiotechNews #USHealthcare #OrthocellRemplir #InvestorUpdate #ProactiveInvestors #SurgicalInnovation #ASX…

Proactive - Interviews for investors

1
Arc Minerals expands portfolio with acquisition of Chingola Copper Project in Zambia 11:08

2 days ago11:08

11:08

Arc Minerals Limited (AIM:ARCM) executive chairman Nick von Schirnding and chief operating officer Vassilios Carellas joined Stephen Gunnion in the Proactive studio with details of the company’s latest acquisition—the Chingola Copper Project in Zambia. Von Schirnding highlighted that the project is located in the northeast of the Zambian Copper Belt, an area known for high-grade copper deposits. The site is less than 30km from major existing operations, including Vedanta’s Nchanga Mine and Moxico Resources’ Mimbula Mine. He described the acquisition as strategic, adding that Arc Minerals has been pursuing it for 18 months due to its high prospectivity. Carellas detailed the financial terms of the deal, explaining that Arc Minerals has committed an initial $75,000, with milestone-based payments tied to drilling and resource confirmation. He emphasised that the transaction is structured to limit financial risk, allowing the company to exit if exploration does not yield the expected results. Von Schirnding also reassured investors that the company’s upcoming exploration work at Chingola is fully funded, with soil sampling expected to commence soon. The project will add to Arc Minerals’ growing portfolio, which includes its joint venture with Anglo American in Zambia’s northwest and assets in Botswana. Carellas noted that Chingola’s geological potential remains largely untested in the last 20 years, making it a prime target for new exploration techniques. The company expects active news flow as soil sampling and drilling programs progress. Arc Minerals also provided updates on its joint venture with Anglo American, confirming that preparations are underway for drilling to commence soon. Stay tuned for more updates on Arc Minerals’ progress. Don’t forget to like this video, subscribe to Proactive’s YouTube channel, and turn on notifications for the latest updates on mining and investment news. #ArcMinerals #CopperMining #Zambia #MiningInvestment #ChingolaProject #ZambianCopperBelt #MineralExploration #StockMarket #MiningNews #AngloAmerican #CommodityInvesting…

Proactive - Interviews for investors

1
NanoViricides highlights broad-spectrum antiviral strategy and progress with lead drug candidate 6:22

5 days ago6:22

6:22

NanoViricides Chief Financial Officer Meeta Vyas joined Steve Darling from Proactive to share updates on the company’s development of broad-spectrum antiviral therapeutics and its unique positioning amid global market uncertainty. Vyas emphasized that NanoViricides, headquartered in Shelton, Connecticut, conducts all of its research and development in-house, which insulates the company from international tariff fluctuations and supply chain disruptions. At the center of the company’s pipeline is NV-387, a broad-spectrum antiviral drug that differs from vaccines in both function and strategy. Rather than targeting specific viral strains, NV-387 works by mimicking the receptor sites used by over 90% of pathogenic viruses—including influenza, RSV, COVID-19, and smallpox. Vyas explained that this approach helps circumvent the problem of viral mutation, which often renders traditional vaccines less effective. “Regardless of how they mutate, they land on the same receptor site. So we copy the receptor site, which is invariant to mutation,” she said, underscoring the robustness of the NanoViricides platform. She also highlighted supportive regulatory developments in the U.S., noting that the new HHS administration has endorsed a more integrated approach to pandemic preparedness, which includes therapeutics like NV-387 as a key component. In light of recent USDA funding initiatives aimed at combating H5N1 avian flu, Vyas said the company is keen to explore applications of NV-387 in that space as well. Currently, NanoViricides is conducting a Phase 2 clinical trial targeting smallpox, following successful Phase 1 results with no reported adverse effects. #proactiveinvestors #nanoviricidesinc #nyseamerican #nnvc NV387 #BroadSpectrumAntiviral #BiotechStocks #AntiviralTherapeutics #SmallpoxTreatment #BirdFlu #RSV #COVID19Treatment #ProactiveInvestors #PharmaInnovation #MeetaVyas #HHS #PandemicPreparedness…

Proactive - Interviews for investors

1
Solvonis Therapeutics engages PharmaVentures to support key AUD assets 5:53

5 days ago5:53